Bendamustine HCl Monohydrate Drying Process
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for obtaining dry bendamustine hydrochloride monohydrate result in significant yield loss and contamination due to high solubility in acetone-water mixtures and susceptibility to hydrolytic degradation from excessive moisture, with a risk of overdrying leading to undesired by-products.
Innovation Solution
A method involving initial drying of wet bendamustine hydrochloride monohydrate under controlled conditions to achieve a moisture content of 4.4% to 19% by weight, followed by exposure to an inert gas with controlled relative humidity to produce dry bendamustine hydrochloride monohydrate, minimizing impurities and maintaining the desired water of crystallization.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If bendamustine hydrochloride monohydrate is dried using humidified nitrogen (35% to 60% relative humidity), then the product can be obtained, but significant yield loss occurs due to high solubility in acetone-water mixtures and hydrolytic degradation from excessive moisture
Solution Approach 1:
The drying process is divided into two distinct stages: first drying the wet filter cake to reduce moisture content to 4-10%, then conducting acetone washing, and finally a second drying stage to achieve the desired water content of 4.4%. This segmentation allows optimization of each stage to avoid both yield loss and hydrolytic degradation.
Solution Approach 2:
The patent controls the water content parameter throughout the drying process, specifically maintaining it within 4-10% during the first drying stage and achieving 4.4% in the final product. This precise parameter control prevents hydrolytic degradation while maximizing yield.
2Loss of substance
If vigorous drying conditions are used to remove excess water, then moisture content is reduced, but overdrying occurs resulting in loss of water of crystallization and formation of degradation by-products
Solution Approach 1:
The drying process incorporates monitoring and control of water content to provide feedback on the drying progress. This allows the process to be stopped at the precise point where excess water is removed but water of crystallization is preserved, preventing overdrying and degradation by-product formation.
Solution Approach 2:
The patent specifies precise water content parameters (4-10% during drying, 4.4% in final product) to control the drying process. By maintaining water content within these ranges, the process removes excess water while preserving the monohydrate form and preventing degradation.
3Manufacturing precision
If acetone washing is performed on wet filter cake, then purity is improved, but significant yield loss occurs due to high solubility of bendamustine hydrochloride monohydrate in acetone-water mixtures
Solution Approach 1:
The process segments the washing operation to occur after the first drying stage rather than on the wet filter cake. This timing optimization reduces solubility losses while maintaining purity benefits, thereby improving yield without sacrificing manufacturing precision.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach achieves high yields of dry bendamustine hydrochloride monohydrate with low levels of impurities, such as monohydroxy-bendamustine, while avoiding overdrying and maintaining the monohydrate form, thus enhancing product stability and purity.
Implementation Method 1
drying of water-wet bendamustine hydrochloride monohydrate, whereby high yields of the desired product, which is substantially free of water in excess of the single water of crystallization, are obtained
Implementation Method 2
bendamustine has been found to be susceptible to hydrolytic degradation upon prolonged exposure to excessive moisture, resulting in the generation of the undesired contaminant monohydroxy-bendamustine
Data Source
AI summary
Wet bendamustine hydrochloride monohydrate may be dried by a two stage process wherein rapid drying is first carried out to provide a partially dried product, which is then further dried using an inert gas of controlled relative humidity to yield dry bendamustine hydrochloride monohydrate.